Adverse drug reactions: An update review of the problem in Spain;Reacciones adversas a medicamentos: Una revisión actualizada del problema en España

Revista Clinica Espanola

Volumn 206, Issue 7, 2006, Pages 336-339

  Puche Canas E ^a   de Dios Luna, J ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMIODARONE; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; BENZOIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CORTICOSTEROID; CORTICOTROPIN; CYTOSTATIC AGENT; DICLOFENAC; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYPNOTIC SEDATIVE AGENT; INSULIN; KETOROLAC; LITHIUM; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT; SULFONYLUREA DERIVATIVE; UNINDEXED DRUG; VASODILATOR AGENT;

AGE; APLASIA; APNEA; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLASSIFICATION; COMORBIDITY; DIGESTIVE SYSTEM HEMORRHAGE; DISEASE SEVERITY; DRUG FATALITY; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; ENDOCRINE DISEASE; FREQUENCY ANALYSIS; GASTROINTESTINAL DISEASE; GENDER; HEADACHE; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEPATITIS; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INCIDENCE; LENGTH OF STAY; MEDICAL LITERATURE; NAUSEA AND VOMITING; NOTE; OBSERVATIONAL STUDY; PUBLICATION; RESPIRATORY TRACT DISEASE; SEDATION; SKIN DISEASE; SOMNOLENCE; SPAIN; STOMATITIS; TACHYCARDIA; THROMBOCYTOPENIA;

EID: 33746879157     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13090482     Document Type: Article

References (24)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA. 1998;279:1200-5.
2. Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18:275-80.
3. Seidl IG, Thornton GF, Cluff LE. Epidemiological studies of adverse drug reactions. Am J Pub Health. 1965;55:1170-6.
4. Ogilvie RI, Ruedy S. Adverse reactions during hospitalization. Can Med Ass J. 1967;97:1445-57.
5. Borda IG, Slone D, Jick H. Assessment of adverse drug reactions within a drug surveillance program. JAMA. 1968; 205:645-7.
6. Hurwitz N, Wade O. Intensive hospital monitoring of adverse reactions to drug. Br Med J. 1969;1:531-6.
7. Aronson JK, Derry S, Loke YK. Adverse drug reactions: keeping up to date. Fundam Clin Pharmacol. 2002;16:49-56.
8. Ferner RE, Aronson JK. National differences in publishing papers on adverse drug reactions. Br J Clin Pharmacol. 2005;59:108-11.
9. Gandhi T, Burstin H, Cook F, Puopolo A, Haas J, Brennan T, et al. Drug complications in outpatients. J Gen Intern Med. 2000;15:149-54.
10. Wiffen P, Gill M, Moore A. Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Junio 2002. Disponible en: www.ebandolier.com
11. McDonell P, Jacobs M. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331-6.
12. Abajo F, Frías J, Lopo C, Garijo B, Castro M, Carcas A, et al. Las reacciones adversas a medicamentos como motivo de consulta al servicio de urgencias de un hospital general. Med Clin (Barc). 1989;92:530-5.
13. De Frutos M, Lázaro A, Llenares V, Aspiazu M, Serrano A, López F. Reacciones adversas a medicamentos en un centro de salud. Atención Primaria. 1994;14:783-6.
14. Zoppi M, Braunschweig S, Kuenzi UP, Maibach R, Hoigné R. Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on data of Berne/St. Gallen. Eur J Clin Pharmacol. 2000;56:427-30.
15. Juntti-Patinen L, Neuvonen PJ. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol. 2002;58:479-82.
16. Rubin JM, Hevia S, Veganzones A, Barriales V. Estudio del bloqueo auriculoventricular secundario a betabloqueantes oculares tópicos. Rev Esp Cardiol. 1999;52:532.
17. Einarson TR. Drug-related hospital admission. Ann Pharmacother. 1993; 27:832-40.
18. Beijer HJM, de Blaey CJ. Hospitalizations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002; 24:46-54.
19. Pimohamed M, James S, Meakin S, Green C, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Br Med J. 2005;329:15-9.
20. Ajayi FO, Sun H, Perry J. Adverse drug reactions: a review of relevant factors. J Clin Pharmacol. 2000;40:1093-101.
21. Adverse drug interactions (editorial). JAMA. 1972;220:1238-9.
22. Walker J, Wynne H. Review: The frequency and severity of adverse drug reactions in elderly people. Age Aging. 1994;23:255-9.
23. Roughead E, Gilbert A, Primrose J, Sansom L. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust. 1998;168:405-8.
24. Moride Y, Haramburu F, Requejo A, Bégaud B. Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol. 1997;43: 177-81.